Yahoo Web Search

Search results

    • Here's Why Eli Lilly Stock Remains a Screaming Buy

      Here's Why Eli Lilly Stock Remains a Screaming Buy

      Motley Fool via Yahoo Finance· 12 hours ago

      Lilly plans to file for regulatory approvals this year for tirzepatide in treating obstructive sleep apnea, which should open up the big Medicare market....